SARSCoV2

Study: Promising natural products against SARS-CoV-2: Structure, function, and clinical trials. Image Credit: Olga Larionova/Shutterstock

A review of natural products with promising potential against SARS-CoV-2

In a recent review published in Phytotherapy researchresearchers reviewed the existing literature on naturally active products with therapeutic efficacy against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Study: Promising natural products against SARS-CoV-2: Structure, function and clinical studies. Image credit: Olga Larionova/Shutterstock Studies have reported breakthrough infections with coronavirus disease 2019 (COVID-19) and multiple mutations …

A review of natural products with promising potential against SARS-CoV-2 Read More »

Study: Dynamics of Competing SARS-Cov-2 Variants During the Omicron Epidemic in England. Image Credit: Mayboon / Shutterstock.com

Additional SARS-CoV-2 variants and sporadic epidemics may become the ‘new normal’

The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) led to the coronavirus disease 2019 (COVID-19) pandemic, which has so far claimed more than 6.4 million deaths. Despite rigorous efforts to contain the transmission of the virus, SARS-CoV-2 spread rapidly and mutated several times. This led to the emergence of new variants of SARS-CoV-2 …

Additional SARS-CoV-2 variants and sporadic epidemics may become the ‘new normal’ Read More »

Consequences of the emergence and spread of SARS-CoV-2 variants of concerns BA.4 and BA.5 for the EU / EEA

Consequences of the emergence and spread of SARS-CoV-2 variants of concerns BA.4 and BA.5 for the EU / EEA

Event background SARS-CoV-2 variants BA.4 and BA.5 were first detected in South Africa in January and February 2022. They became the dominant variants in this country in May 2022. [1] and a parallel growing trend in epidemiological indicators such as the number of reported cases and the positivity rate of tests [2]suggested that these two …

Consequences of the emergence and spread of SARS-CoV-2 variants of concerns BA.4 and BA.5 for the EU / EEA Read More »

Additional doses of SARS-CoV-2 increase the antibody response in patients with IBD

Source / Publication Published: Source: Quan J, et al. Poster 654. Presented at: Digestive Disease Week; 21-24 May 2022; San Diego (hybrid meeting). Disclosure: Quan has no relevant financial information. ADD TOPIC TO E-MAIL NOTIFICATIONS Receive email when new articles are published Please enter your e-mail address to which you will be sent an e-mail …

Additional doses of SARS-CoV-2 increase the antibody response in patients with IBD Read More »